The National HBPA, which represents nearly 30,000 Thoroughbred owners and trainers in North America, has released a video stating the association’s opposition to proposed federal oversight of the horse racing industry’s medication and testing.
Specifically, the video highlights the fact that race-day Lasix, which would not be allowed under the proposed legislation, is a proven therapeutic that prevents injuries. That statement is backed up by the American Association of Equine Practitioners (AAEP) and the North American Association of Racetrack Veterinarians (NAARV).
“To the horsemen of the HBPA, NOTHING is more important than keeping our beautiful racehorses safe,” said National HBPA CEO Eric Hamelback, who is featured in the video. “We are constantly striving to improve safety for our horses and their jockeys, but federal oversight is not the answer.”
The National HBPA encourages horsemen and racing fans to share this video on social media.